Literature DB >> 29249552

Pretreatment Cognition in Patients Diagnosed With Pediatric Brain Tumors.

Elin Irestorm1, Sean Perrin2, Ingrid Tonning Olsson3.   

Abstract

BACKGROUND: There is a large body of literature identifying risk factors for the long-term cognitive alterations found in survivors of pediatric brain tumors. Less is known about baseline cognitive functioning in this population, but studies suggest that cognitive dysfunctions are often present at the time of diagnosis. This study aimed to identify potential risk factors for lower cognitive function at the time of pediatric brain tumor diagnosis.
METHODS: Participants were children and adolescents (n = 101) diagnosed with a pediatric brain tumor between 2006 and 2015, who underwent a pretreatment neuropsychologic assessment. Multivariate regression models were used to estimate the association between gender, age at diagnosis, tumor size and location, increased intracranial pressure, epilepsy, and six different indicators of cognitive functioning.
RESULTS: Overall, cognitive performance was relatively intact, with results close to norm means, but impairments were found in memory and cognitive processing speed. Male gender, older age, epilepsy, increased intracranial pressure, and larger tumors were all associated with lower cognitive function at the time of brain tumor diagnosis; whereas tumor location was not.
CONCLUSIONS: Pretreatment neuropsychologic assessments, with some adjustments, can be carried out with children and adolescents with brain tumors. Our study adds to a small but growing body of literature documenting cognitive impairments at the time of diagnosis; these impairments may partly explain the longer-term deficits that commonly occur in pediatric brain tumor survivors. Consistent with previous research, pretreatment impairments were more common among boys, older children, and those with increased intracranial pressure, epilepsy, and larger tumors. The relationship between baseline and longer-term cognitive deficits requires further examination.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  age; increased intracranial pressure; neuropsychologic assessment; pediatric brain tumor; pretreatment cognition

Mesh:

Year:  2017        PMID: 29249552     DOI: 10.1016/j.pediatrneurol.2017.11.008

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  2 in total

1.  Neurocognitive impairment following proton therapy for paediatric brain tumour: a systematic review of post-therapy assessments.

Authors:  Noorazrul Yahya; Hanani Abdul Manan
Journal:  Support Care Cancer       Date:  2020-10-11       Impact factor: 3.603

2.  Cognitive fatigue in relation to depressive symptoms after treatment for childhood cancer.

Authors:  Elin Irestorm; Ingrid Tonning Olsson; Birgitta Johansson; Ingrid Øra
Journal:  BMC Psychol       Date:  2020-04-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.